Spero Therapeutics
SPRO
SPRO
54 hedge funds and large institutions have $17.2M invested in Spero Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less capital invested
Capital invested by funds: $20.8M → $17.2M (-$3.66M)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $73K
Holders
54
Holding in Top 10
2
Calls
–
Puts
$73K
Top Buyers
| 1 | +$865K | |
| 2 | +$121K | |
| 3 | +$118K | |
| 4 |
Squarepoint
New York
|
+$62.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.7K |
Top Sellers
| 1 | -$741K | |
| 2 | -$308K | |
| 3 | -$81.7K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$69.9K |
| 5 |
AIC
AWM Investment Company
New York
|
-$60.5K |